Quick Read - MSFT has dropped 22% year to date, offering a 19x forward P/E against 23% earnings growth and four straight consensus beats. - Microsoft's commercial backlog hit $627 billion, nearly doubling year over year, with 25% converting to revenue in the next 12 months. -...<
MicroStrategy adopts a new framework allowing Bitcoin sales and $2 billion in stock buybacks to address its undervalued shares. MicroStrategy Inc. abandoned its "never sell" Bitcoin strategy, introducing a Digital Credit Capital Framework to monetize its holdings. The comp
Not all businesses are at the same stage of their life cycles. Some companies offer a more exciting opportunity to investors They are able to quickly increase their sales and profits, most likely resulting from powerful tailwinds pushing them forward. Along the same
US stocks have been predicted to extend their recovery on Tuesday, as investors approach the final session of a second quarter that has delivered a strong rebound for many risk assets. Futures pointed to a slightly firmer open, with S&P 500 futures up 0.1%, Nasdaq futures
Futures for the Dow Jones Industrial Average and other major stock indexes traded higher Tuesday, as Wall Street awaited the release of key economic data. Meanwhile, AeroVironment (AVAV) was an early winner on the stock market today Ahead of Tuesday's opening bell, Dow fut
A Huron Consulting Director Sold Over 1,800 Company Shares. Here's a Closer Look at the Transaction Board of Directors member Joy Brown sold 1,821 shares of Huron Consulting Group (NASDAQ:HURN) for approximately $191,000 in open-market transactions on May 22, 2026,
Joby Aviation forms joint venture with Toyota to manufacture S4 aircraft Joby Aviation's subsidiary, Joby Aero, has entered into a stockholders agreement with Toyota Motor Corporation to form a joint venture. The joint venture aims to manufacture Joby Aviation's S4 el
Direxion’s QQQE ETF cuts top-heavy exposure by equally weighting Nasdaq-100 stocks, lowering reliance on megacap tech. The Direxion NASDAQ-100 Equal Weighted Index ETF (QQQE) addresses concentration risks in the Invesco QQQ ETF (QQQ) by equally weighting its holdings. QQQ’
Recursion Pharmaceuticals reports $74.7 million revenue for fiscal 2025, up 26.9% year-over-year, amid a $644.8 million net loss. Recursion Pharmaceuticals (NASDAQ:RXRX) reported nearly $74.7 million in revenue for fiscal 2025, a 26.9% increase year-over-year. The growth r
Quick Read - Comcast's Versant cable spinoff made the conglomerate unbundling playbook explicit, proving the structural discount is now a closing window across the S&P 500. - Honeywell rallied 16.8% year to date executing its breakup while Intel surged 257% as markets price in a...</stron
ادخل بحساب جوجل لمشاركة رأيك والتفاعل مع الأخبار — بلا كلمة مرور.
إيميلك يبقى موثّقاً وخصوصيتك محفوظة.